- List
- By Topic
- On Map
- Search Details

Recruiting, Not yet recruiting, Available Studies | "Pregnancy Complications, Neoplastic"
Need help? See RSS Feeds
Choose a feed type:

Recruiting, Not yet recruiting, Available Studies | "Pregnancy Complications, Neoplastic" (15 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT02749474 | Recruiting | Maternal Cancer Diagnosis and Treatment During Pregnancy:a Database for Maternal, Fetal, and Neonatal Outcomes |
|
Observational |
|
Other |
|
|
400 | Female | Child, Adult, Senior | NCT02749474 | Cooper 15-028 | CANCRPREGREG | July 2003 | July 2023 | July 2023 | April 25, 2016 | July 24, 2017 |
|
|||
2 | NCT03488901 | Not yet recruiting New |
Chemoresistance of Trophoblastic Tumors |
|
|
Observational |
|
Other |
|
|
72 | Female | 18 Years to 60 Years (Adult) | NCT03488901 | 69HCL16_807 | PrediCTTro | April 2018 | October 2018 | December 2018 | April 5, 2018 | April 5, 2018 |
|
||
3 | NCT03135769 | Recruiting | Avelumab in Chemo-resistant Gestational Trophoblastic Neoplasias |
|
|
Interventional | Phase 2 |
|
Other |
|
|
29 | Female | 18 Years and older (Adult, Senior) | NCT03135769 | 69HCL16_0123 | TROPHIMMUN | February 21, 2017 | May 2019 | February 2023 | May 1, 2017 | August 23, 2017 |
|
|
4 | NCT02892877 | Recruiting | The French National Reference Centre of GTD |
|
Observational |
|
Other |
|
|
25500 | Female | Child, Adult, Senior | NCT02892877 | 69HCL16_0519 | French GTDC | November 1999 | November 2029 | November 2029 | September 8, 2016 | September 8, 2016 |
|
|||
5 | NCT02639650 | Not yet recruiting | Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic Tumor |
|
|
Interventional | Phase 3 |
|
Other |
|
|
214 | Female | up to 60 Years (Child, Adult) | NCT02639650 | ZJHGTN1211 | March 2016 | March 2019 | March 2021 | December 24, 2015 | December 24, 2015 | |||
6 | NCT03280979 | Not yet recruiting | Rescue Regimen and High Dose Methotrexate in Management of Presistent Gestational Trophoplastic Neoplasia |
|
|
Interventional | Phase 2 Phase 3 |
|
Other |
|
|
170 | Female | 18 Years to 50 Years (Adult) | NCT03280979 | RR&HDMPGTN | October 2017 | July 2019 | October 2019 | September 13, 2017 | September 13, 2017 | |||
7 | NCT01008501 | Recruiting | Study of the Genetic and Epigenetic Causes of Recurrent Hydatidiform Moles |
|
Observational |
|
Other |
|
100 | All | Child, Adult, Senior | NCT01008501 | BCM Hydatidiform Mole H7345 | December 1998 | January 2020 | January 2020 | November 5, 2009 | January 9, 2018 |
|
|||||
8 | NCT03426865 | Recruiting | Role of Axumin PET Scan in Germ Cell Tumor |
|
|
Interventional | Phase 2 |
|
Other |
|
|
10 | Male | 18 Years and older (Adult, Senior) | NCT03426865 | 032017-051 | TESTPET | February 15, 2018 | December 31, 2018 | January 31, 2019 | February 8, 2018 | February 8, 2018 |
|
|
9 | NCT03067181 | Recruiting | Active Surveillance, Bleomycin, Carboplatin, Etoposide, or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors |
|
|
Interventional | Phase 3 |
|
Other / NIH |
|
|
1680 | All | up to 49 Years (Child, Adult) | NCT03067181 | AGCT1531 NCI-2017-00178 |
May 8, 2017 | December 2022 | December 2022 | March 1, 2017 | June 6, 2017 |
|
||
10 | NCT02664961 | Recruiting | Study of TRC105 and Bevacizumab in Patients With Refractory Gestational Trophoblastic Neoplasia (GTN) |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
30 | All | 16 Years to 99 Years (Child, Adult, Senior) | NCT02664961 | 105GTN201 | March 2016 | August 2017 | August 2017 | January 27, 2016 | November 2, 2016 |
|
||
11 | NCT02834013 | Recruiting | Nivolumab and Ipilimumab in Treating Patients With Rare Tumors |
|
|
Interventional | Phase 2 |
|
NIH |
|
|
707 | All | 18 Years and older (Adult, Senior) | NCT02834013 | NCI-2016-01041 S1609 U10CA180888 |
January 13, 2017 | August 31, 2020 | July 15, 2016 | April 17, 2018 |
|
|||
12 | NCT02375204 | Recruiting | Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors |
|
|
Interventional | Phase 3 |
|
Other / NIH |
|
|
420 | Male | 14 Years and older (Child, Adult, Senior) | NCT02375204 | A031102 U10CA180821 NCI-2014-01696 |
March 2015 | June 2024 | March 2, 2015 | April 9, 2018 |
|
|||
13 | NCT01630954 | Recruiting | A Comparison of Single Versus Double Evacuation for Treatment of Hydatidiform Mole |
|
|
Interventional | Phase 4 |
|
Other |
|
|
120 | Female | 15 Years to 45 Years (Child, Adult) | NCT01630954 | 4-Chaudhuri | June 2012 | December 2018 | June 2019 | June 28, 2012 | March 23, 2016 |
|
||
14 | NCT01764802 | Recruiting | Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer |
|
|
Interventional | Phase 2 |
|
Other / NIH |
|
|
100 | Female | 21 Years to 80 Years (Adult, Senior) | NCT01764802 | OSU-10077 NCI-2012-01341 1R21CA149675-01A1 |
October 2010 | August 2018 | January 10, 2013 | April 13, 2017 |
|
|||
15 | NCT01434355 | Recruiting | DNA Analysis in Samples From Younger Patients With Germ Cell Tumors and Their Parents or Siblings |
|
|
Observational |
|
Other / NIH |
|
|
932 | All | up to 19 Years (Child, Adult) | NCT01434355 | AEPI10N1 NCI-2011-03464 COG-AEPI10N1 |
November 2011 | August 2018 | September 14, 2011 | October 9, 2017 |
|
† Study has passed its completion date and status has not been verified in more than two years.